Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Comment on Neuromyelitis Optica: Potential Roles for Intravenous Immunoglobulin.
Current status of myelin replacement therapies in multiple sclerosis.
Viability of autoantibody-targets: How to tackle pathogenetic heterogeneity as an obstacle for treatment of multiple sclerosis.
A case of acute disseminated encephalomyelitis associated with hepatitis C virus infection.
2-BFI ameliorates EAE-induced mouse spinal cord damage: Effective therapeutic time window and possible mechanisms.
Possible role of interleukin-17 in a prime/challenge model of multiple sclerosis.
Spatial modeling of multiple sclerosis for disease subtype prediction.
[Differential diagnosis of multiple sclerosis with pediatric onset: the experience of the Moscow Division for treatment of children and adolescents with multiple sclerosis.]
Preparation and characterization of Δ(9)-tetrahydrocannabinol-loaded biodegradable polymeric microparticles and their antitumoral efficacy on cancer cell lines.
Tolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1+ and IL-10-producing splenic macrophages and maintained by T regulatory cells.
Minocycline-induced attenuation of iron overload and brain injury after experimental intracerebral hemorrhage.
Depression in multiple sclerosis: A long-term longitudinal study.
Simvastatin treatment does not protect retinal ganglion cells from degeneration in a rat model of autoimmune optic neuritis.
Cervical dysplasia associated with the use of natalizumab.
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases.
Kinetics of Proinflammatory Monocytes in a Model of Multiple Sclerosis and Its Perturbation by Laquinimod.
Aggregation of MBP in chronic demyelination.
Validation survey of the impact of urinary incontinence (IIQ-7) and inventory of distress urogenital (UDI-6) - the short scales - in patients with multiple sclerosis.
Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy.
Distinguishing Susac's syndrome from multiple sclerosis.
The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE).
A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis.
Simvastatin as an Add-on Treatment to Interferon-beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis (SIMCOMBIN)
Olig1 function is required for remyelination potential of transplanted neural progenitor cells in a model of viral-induced demyelination.
Management of optic neuritis as a clinically first event of multiple sclerosis.

Pages